Kidney Cancer

Latest News

Microbiome-based therapy shows promise in solid tumors, including ccRCC
Microbiome-based therapy shows promise in solid tumors, including ccRCC

June 17th 2024

"The positive trends emerging from the ongoing phase 1 trial of BMC128, particularly in combination with nivolumab, underscore the transformative potential of microbiome-based therapeutics in oncology,” says Gal Markel, MD, PhD, MBA.

Expert discusses study of histotripsy in small renal masses
Expert discusses study of histotripsy in small renal masses

May 30th 2024

Anti-CD70 CAR-NKT therapy shows promise in renal cell carcinoma
Anti-CD70 CAR-NKT therapy shows promise in renal cell carcinoma

May 23rd 2024

Study to evaluate DF9001 plus pembrolizumab in solid tumors, including RCC
Study to evaluate DF9001 plus pembrolizumab in solid tumors, including RCC

May 22nd 2024

Dosing commences in phase 1/2 trial of AB-2100 in ccRCC
Dosing commences in phase 1/2 trial of AB-2100 in ccRCC

May 15th 2024

© 2024 MJH Life Sciences

All rights reserved.